Clinical Trial Detail

NCT ID NCT01747551
Title FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Aflibercept

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Age Groups: adult

No variant requirements are available.